Vicarious Surgical (RBOTW) Return on Capital Employed (2021 - 2025)
Vicarious Surgical (RBOTW) reported Return on Capital Employed of 174.52% for Q3 2025, down 8889.0% year-over-year from 1.99% in Q3 2024, and down 20.68% on a QoQ basis from 144.61% in Q2 2025.
Vicarious Surgical (RBOTW) has 5 years of Return on Capital Employed data on file, last reported at 174.52% in Q3 2025.
- Quarterly Return on Capital Employed fell 8889.0% year-over-year to 174.52% in Q3 2025, while the trailing twelve-month figure through Sep 2025 was 174.52% (down 8889.0% YoY) and the FY2024 annual result came in at 77.28%, down 1159.0% from the prior year.
- Return on Capital Employed eased to 174.52% in Q3 2025 per RBOTW's latest filing, from 144.61% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 5.52% in Q2 2021 and bottomed at 174.52% in Q3 2025.
- The 5-year median for Return on Capital Employed is 67.97% (2023), against an average of 68.0%.
- The widest annual swing landed in 2024, when Return on Capital Employed soared 542 bps; it then plunged 8889 bps in 2025.
- Tracing RBOTW's Return on Capital Employed over 5 years: stood at 21.09% in 2021, then tumbled by 177 bps to 58.41% in 2022, then retreated by 16 bps to 67.97% in 2023, then sank by 47 bps to 100.08% in 2024, then slumped by 74 bps to 174.52% in 2025.
- Per Business Quant, the three latest RBOTW Return on Capital Employed figures stand at 174.52% (Q3 2025), 144.61% (Q2 2025), and 123.65% (Q1 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 9.61% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 12.24% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 7.36% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 9.62% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 11.13% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 7.62% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 24.24% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 9.30% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 11.57% |
| 10 | Vicarious Surgical | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -174.52% |
| Jun 30, 2025 | -144.61% |
| Mar 31, 2025 | -123.65% |
| Dec 31, 2024 | -100.08% |
| Sep 30, 2024 | -85.63% |
| Jun 30, 2024 | -76.75% |
| Mar 31, 2024 | -69.27% |
| Dec 31, 2023 | -67.97% |
| Sep 30, 2023 | -77.60% |
| Jun 30, 2023 | -82.17% |
| Mar 31, 2023 | -67.90% |
| Dec 31, 2022 | -58.41% |
| Sep 30, 2022 | -53.05% |
| Jun 30, 2022 | -38.57% |
| Mar 31, 2022 | -29.34% |
| Dec 31, 2021 | -21.09% |
| Sep 30, 2021 | -9.08% |
| Jun 30, 2021 | -5.52% |
| Mar 31, 2021 | -6.86% |